Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 12:4:17.
doi: 10.1186/1550-2783-4-17.

Comparison of new forms of creatine in raising plasma creatine levels

Affiliations

Comparison of new forms of creatine in raising plasma creatine levels

Ralf Jäger et al. J Int Soc Sports Nutr. .

Abstract

Background: Previous research has shown that plasma creatine levels are influenced by extracellular concentrations of insulin and glucose as well as by the intracellular creatine concentration. However, the form of creatine administered does not appear to have any effect although specific data on this is lacking. This study examined whether the administration of three different forms of creatine had different effects on plasma creatine concentrations and pharmacokinetics.

Methods: Six healthy subjects (three female and three male subjects) participated in the study. Each subject was assigned to ingest a single dose of isomolar amounts of creatine (4.4 g) in the form of creatine monohydrate (CrM), tri-creatine citrate (CrC), or creatine pyruvate (CrPyr) using a balanced cross-over design. Plasma concentration curves, determined over eight hours after ingestion, were subject to pharmacokinetic analysis and primary derived data were analyzed by repeated measures ANOVA.

Results: Mean peak concentrations and area under the curve (AUC) were significantly higher with CrPyr (17 and 14%, respectively) in comparison to CrM and CrC. Mean peak concentration and AUC were not significantly different between CrM and CrC. Despite the higher peak concentration with CrPyr there was no difference between the estimated velocity constants of absorption (ka) or elimination (kel) between the three treatments. There was no effect of treatment with CrPyr on the plasma pyruvate concentration.

Conclusion: The findings suggest that different forms of creatine result in slightly altered kinetics of plasma creatine absorption following ingestion of isomolar (with respect to creatine) doses of CrM, CrC and CrPyr although differences in ka could not be detected due to the small number of blood samples taken during the absorption phase. Characteristically this resulted in higher plasma concentrations of creatine with CrPyr. Differences in bioavailability are thought to be unlikely since absorption of CrM is already close to 100%. The small differences in kinetics are unlikely to have any effect on muscle creatine elevation during periods of creatine loading.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean plasma creatine concentration over 8 hours following ingestion of 4.4 g of Creatine in the form of creatine monohydrate (CrM), tri-creatine citrate (CrC), or creatine pyruvate (CrPyr). Dispersions and statistical significances are given in table 2.
Figure 2
Figure 2
Mean plasma pyruvate concentrations during 8 hours following ingestion of creatine pyruvate (CrPyr, 7.3 g), creatine monohydrate (CrM, 5 g) or tri-creatine citrate (CrC, 6.7 g).

Similar articles

Cited by

References

    1. Harris RC, Söderlund K, Hultman E. Evaluation of Creatine in resting and exercised muscle of normal subjects by Creatine supplementation. Clin Sci (Lond) 1992;83:367–374. - PubMed
    1. Terjung RL, Clarkson P, Eichner ER, Greenhaff PL, Hespel PJ, Israel RG, Kraemer WJ, Meyer RA, Spriet LL, Tarnopolsky MA, Wagenmakers AJM, Williams MH. The American College of Sports Medicine Roundtable on the physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc. 2000;32:706–717. doi: 10.1097/00005768-200003000-00024. - DOI - PubMed
    1. Williams MH, Kreider RB, Branch JD. Creatine: the power supplement. Champaign: Human Kinetics; 1999.
    1. Chanutin A. The fate of creatine when administered to man. J Biol Chem. 1926;67:29–41.
    1. Deldicque L, Décombaz J, Zbinden Foncea H, Vuichoud J, Poortmans JR, Francaux M. Kinetics of creatine ingested as a food ingredient. Eur J Appl Physiol. 2008;102:133–143. doi: 10.1007/s00421-007-0558-9. - DOI - PubMed